Guided Therapeutics (GTHP) EBITDA (2010 - 2026)
Guided Therapeutics' (GTHP) quarterly EBITDA came in at -$478000.0 in Q2 2026, up 37.35% year-over-year from -$348009.5 in Q2 2025, and down 58.28% quarter-over-quarter from -$302000.0 in Q1 2026.
Powered by 
Analysis
Guided Therapeutics (GTHP) EBITDA (2010 - 2026) Analysis & Trends
Guided Therapeutics has disclosed EBITDA across 17 years of filings, most recently posting -$478000.0 for Q2 2026.
- In Q2 2026, EBITDA rose 37.35% year-over-year to -$478000.0; the TTM figure through Jun 2026 stood at -$2.0 million (up 13.07% YoY), while the FY2025 annual figure was -$2.4 million, down 12.52% from the prior year.
- EBITDA came in at -$478000.0 for Q2 2026 at Guided Therapeutics, down from -$302000.0 in the prior quarter.
- In the past five years, EBITDA ranged from a high of -$302000.0 in Q1 2026 to a low of -$1.5 million in Q2 2023.
- Average EBITDA over 5 years is -$669388.9, with a median of -$592000.0 recorded in 2023.
- Year-over-year, EBITDA slumped 151.33% in 2022 and surged 57.41% in 2024.
- Over 5 years, EBITDA stood at -$948000.0 in 2022, then soared by 48.84% to -$485000.0 in 2023, then declined by 10.1% to -$534000.0 in 2024, then tumbled by 32.96% to -$710000.0 in 2025, then jumped by 32.68% to -$478000.0 in 2026.
- Per Business Quant data, the three most recent EBITDA figures were -$478000.0 in Q2 2026, -$302000.0 in Q1 2026, and -$710000.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 1.69 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 971.90 Mn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 1.76 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 1.66 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 1.18 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 513.20 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 11.00 Mn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 318.30 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 285.80 Mn |
| 10 | Guided Therapeutics | 24.13 Mn | 24.12 Mn | - | -478,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -478,000.00 |
| Mar 31, 2026 | -302,000.00 |
| Dec 31, 2025 | -710,000.00 |
| Sep 30, 2025 | -485,000.00 |
| Jun 30, 2025 | -763,000.00 |
| Mar 31, 2025 | -414,000.00 |
| Dec 31, 2024 | -534,000.00 |
| Sep 30, 2024 | -561,000.00 |
| Jun 30, 2024 | -655,000.00 |
| Mar 31, 2024 | -359,000.00 |
| Dec 31, 2023 | -485,000.00 |
| Sep 30, 2023 | -623,000.00 |
| Jun 30, 2023 | -1.51 Mn |
| Mar 31, 2023 | -843,000.00 |
| Dec 31, 2022 | -948,000.00 |
| Sep 30, 2022 | -1.22 Mn |
| Jun 30, 2022 | -717,000.00 |
| Mar 31, 2022 | -443,000.00 |
| Dec 31, 2021 | -435,000.00 |
| Sep 30, 2021 | -487,000.00 |